Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.68 USD | -0.61% | +3.39% | +201.65% |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call | |
05-13 | Jasper Therapeutics to Expand Mast Cell Portfolio, Initiates Asthma Study in Q4 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+201.65% | 359M | |
+38.76% | 728B | |
+33.05% | 603B | |
-5.51% | 360B | |
+18.91% | 332B | |
+1.46% | 279B | |
+16.00% | 244B | |
+8.09% | 207B | |
-5.77% | 205B | |
+6.41% | 164B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics : BMO Initiates Jasper Therapeutics at Outperform Rating With $19 Price Target